Revenue: As of FY2025 Q4, the actual value is USD 18.6 M, beating the estimate of USD 16.55 M.<h3>Revenue</h3><ul><li>Net Sales<ul><li>Rockwell Medical, Inc. expects net sales for the fourth quarter 2025 to be approximately $18.6 million .</li><li>Net sales for the full-year 2025 are expected to be approximately $69.5 million .</li></ul></li></ul><h3>Operational Metrics</h3><ul><li>Gross Margin<ul><li>The company expects its gross margin for the fourth quarter 2025 to be approximately 22%, which is an increase from 14% in the third quarter 2025 . This improvement is attributed to improved operational efficiencies and reduced expenses .</li></ul></li></ul><h3>Cash Flow</h3><ul><li>Cash Flow from Operations<ul><li>Rockwell Medical, Inc. expects to report cash flow from operations of approximately $2.3 million in the fourth quarter 2025, marking its second cash flow positive quarter in 2025 .</li></ul></li><li>Cash and Cash Equivalents and Investments<ul><li>Cash and cash equivalents and investments available-for-sale are expected to increase to approximately $25 million as of December 31, 2025 .</li></ul></li></ul><h3>Outlook / Guidance</h3>Rockwell Medical, Inc. is strategically focused on increasing revenue, achieving sustainable profitability, and reducing costs . For 2026, the company aims to deliver sustainable profitability and further diversify its product portfolio . These efforts are intended to drive continued growth and create lasting value for shareholders .

Rockwell Medical | 8-K: FY2025 Q4 Revenue Beats Estimate at USD 18.6 M